Halstead Michael — SEC insider filings

SEC reporting owner CIK 1521548. 30 insider filings on record with FilingPulse; latest filed 2026-09-21.

Transaction summary — filings shown

Covers all 30 filings on record, filed 2020-11-19 to 2026-09-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Intra-Cellular Therapies, Inc. (ITCI)President28—50 legs · 616,833 sh · $31,055,92177
CYBIN INC. (CYBN)Chief Executive Officer21 leg · 100,000 sh · $1,347,050——

Insider filings — Halstead Michael

FiledFormIssuerReported transactionsSource
2026-09-214CYBIN INC. (CYBN)Purchase (P): 100,000 @ $13.47EDGAR
2026-09-173CYBIN INC. (CYBN)Holdings only — no transactions reportedEDGAR
2025-04-024Intra-Cellular Therapies, Inc. (ITCI)Disposition to issuer (D): 21,307 @ $132 · Disposition to issuer (D): 40,472 (derivative) · Disposition to issuer (D): 17,916 (derivative) · Disposition to issuer (D): 13,133 (derivative) · Disposition to issuer (D): 24,478 (derivative) · Disposition to issuer (D): 45,454 (derivative) · +4 moreEDGAR
2025-03-104Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 13,133 · Tax withholding (F): 6,718 @ $131.19 · Option exercise (M): 7,345 · Tax withholding (F): 3,757 @ $131.24 · Option exercise (M): 13,133 (derivative) @ $0 · Option exercise (M): 7,345 (derivative) @ $0EDGAR
2025-03-044Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 12,239 · Tax withholding (F): 6,261 @ $128.20 · Option exercise (M): 12,239 (derivative) @ $0EDGAR
2025-02-044Intra-Cellular Therapies, Inc. (ITCI)Grant/award (A): 11,017 @ $0 · Tax withholding (F): 5,691 @ $127 · Grant/award (A): 45,454 (derivative) @ $0EDGAR
2024-11-144Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 22,869 @ $23.94 · Sale (S): 15,105 @ $88.72 · Sale (S): 6,116 @ $89.63 · Sale (S): 1,648 @ $90.89 · Option exercise (M): 18,714 @ $36.89 · Sale (S): 13,371 @ $88.17 · +3 moreEDGAR
2024-03-114Intra-Cellular Therapies, Inc. (ITCI)Sale (S): 12,912 @ $66.14 · Sale (S): 220 @ $66.81 · Option exercise (M): 7,345 · Sale (S): 6,107 @ $65.82 · Sale (S): 1,238 @ $66.70 · Option exercise (M): 7,345 (derivative) @ $0EDGAR
2024-03-084Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 13,132 · Option exercise (M): 13,132 (derivative) @ $0EDGAR
2024-03-054Intra-Cellular Therapies, Inc. (ITCI)Grant/award (A): 36,717 (derivative) @ $0EDGAR
2024-02-274Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 7,907 · Sale (S): 300 @ $68.54 · Sale (S): 7,215 @ $69.54 · Sale (S): 392 @ $70.13 · Option exercise (M): 7,907 (derivative) @ $0EDGAR
2024-02-054Intra-Cellular Therapies, Inc. (ITCI)Grant/award (A): 11,860 @ $0 · Sale (S): 11,146 @ $66.37 · Sale (S): 714 @ $67.17EDGAR
2024-01-124Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 46,115 @ $12.73 · Option exercise (M): 3,885 @ $23.94 · Sale (S): 18,154 @ $66.31 · Sale (S): 30,360 @ $67.10 · Sale (S): 1,486 @ $67.80 · Option exercise (M): 46,115 (derivative) @ $0 · +1 moreEDGAR
2023-11-144Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 15,164 @ $15.47 · Option exercise (M): 34,836 @ $12.73 · Sale (S): 8,933 @ $53.37 · Sale (S): 41,067 @ $54.01 · Option exercise (M): 15,164 (derivative) @ $0 · Option exercise (M): 34,836 (derivative) @ $0EDGAR
2023-07-074/AIntra-Cellular Therapies, Inc. (ITCI)Grant/award (A): 40,472 (derivative) @ $0EDGAR
2023-03-134Intra-Cellular Therapies, Inc. (ITCI)Grant/award (A): 16,708 @ $0 · Sale (S): 14,208 @ $43.20 · Sale (S): 2,500 @ $42.52 · Option exercise (M): 7,344 · Sale (S): 6,868 @ $44.99 · Sale (S): 476 @ $44.15 · +1 moreEDGAR
2023-03-084Intra-Cellular Therapies, Inc. (ITCI)Grant/award (A): 39,398 (derivative) @ $0EDGAR
2023-02-274Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 7,906 · Sale (S): 7,906 @ $47.03 · Option exercise (M): 7,906 (derivative) @ $0EDGAR
2023-02-224Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 11,139 · Sale (S): 9,296 @ $46.56 · Sale (S): 643 @ $47.23 · Sale (S): 1,100 @ $48.68 · Sale (S): 100 @ $49.60 · Option exercise (M): 11,139 (derivative) @ $0EDGAR
2022-12-024Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 50,000 @ $15.47 · Sale (S): 27,204 @ $53.94 · Sale (S): 22,796 @ $53.48 · Option exercise (M): 50,000 (derivative) @ $0EDGAR
2022-03-144Intra-Cellular Therapies, Inc. (ITCI)Grant/award (A): 17,916 (derivative) @ $0 · Grant/award (A): 22,034 (derivative) @ $0EDGAR
2022-02-254Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 7,906 · Sale (S): 3,718 @ $52.38 · Sale (S): 4,188 @ $51.62 · Option exercise (M): 7,906 (derivative) @ $0EDGAR
2022-02-234Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 11,139 · Sale (S): 6,589 @ $55.69 · Sale (S): 4,550 @ $54.98 · Option exercise (M): 11,139 (derivative) @ $0EDGAR
2022-01-114Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 19,639 · Sale (S): 2,504 @ $41.74 · Sale (S): 12,755 @ $40.81 · Sale (S): 4,380 @ $40.12 · Option exercise (M): 19,639 (derivative) @ $0EDGAR
2021-12-234Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 25,000 @ $13.86 · Option exercise (M): 88,146 @ $17.57 · Option exercise (M): 63,717 @ $15.73 · Sale (S): 22,620 @ $48.62 · Sale (S): 104,775 @ $47.84 · Sale (S): 36,434 @ $46.87 · +5 moreEDGAR
2021-02-254Intra-Cellular Therapies, Inc. (ITCI)Grant/award (A): 18,714 (derivative) @ $0 · Grant/award (A): 23,719 (derivative) @ $0EDGAR
2021-02-224Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 11,139 · Sale (S): 10,039 @ $39.28 · Sale (S): 1,100 @ $38.91 · Option exercise (M): 11,139 (derivative) @ $0EDGAR
2021-01-124Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 19,638 · Sale (S): 17,702 @ $32.07 · Sale (S): 1,936 @ $31.65 · Option exercise (M): 19,638 (derivative) @ $0EDGAR
2021-01-054Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 16,160 · Sale (S): 12,986 @ $31.39 · Sale (S): 3,174 @ $30.94 · Option exercise (M): 16,160 (derivative) @ $0EDGAR
2020-11-194Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 75,000 @ $13.86 · Sale (S): 75,664 @ $27.60 · Sale (S): 3,761 @ $27.95 · Option exercise (M): 75,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-11-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1521548 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs